Alban Benezech

Université d'Avignon et des Pays de Vaucluse — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index912citations79works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bacterial Identification and Susceptibility Testing(17), Inflammatory Bowel Disease(16), Esophageal and GI Pathology(15), Genomics and Phylogenetic Studies(14), Gastroesophageal reflux and treatments(10)

Publications78 total

Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study
Digestive and Liver Disease·2025Open Access
Impact of Endometriosis on the Progression of Inflammatory Bowel Diseases: A Multicenter Retrospective Study
Clinical and Translational Gastroenterology·2025Open Access
Effectiveness and Safety of a Second <scp>JAK</scp> Inhibitor in Ulcerative Colitis: The <scp>J2J</scp> Multicentre Study
Alimentary Pharmacology & Therapeutics·2025· 9 citedOpen Access
Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFED
Journal of Crohn s and Colitis·2025· 3 cited
DOP092 Efficacy and safety of a second JAK inhibitor in Ulcerative Colitis : J2J multicenter cohort
Journal of Crohn s and Colitis·2025
P1056 Effectiveness and Safety of Upadacitinib Induction Therapy in Real-World Setting for 234 Patients with Crohn’s Disease: A GETAID Multicentre Cohort Study
Journal of Crohn s and Colitis·2025
Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study
Clinical Gastroenterology and Hepatology·2024· 4 citedOpen Access
Prophylactic Proton Pump Inhibitors in Upper Gastrointestinal Bleeding: Impact and Underprescription in a French Multicentric Cohort
Digestive Diseases and Sciences·2024· 2 cited
P322 Compared Efficacy of Second-Line Treatments for Ulcerative Colitis After Failure of Vedolizumab in First-Line Treatment: A Retrospective Multicenter Study
Journal of Crohn s and Colitis·2024· 4 citedOpen Access
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID
Journal of Crohn s and Colitis·2023· 10 citedOpen Access
ENDOSCOPIC SUBMUCOSAL DISSECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS FOR VISIBLE DYSPLASIA: A FRENCH RETROSPECTIVE MULTICENTRIC STUDY
Gastrointestinal Endoscopy·2023· 1 cited
Sa1820 RISK OF INCIDENT CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH PRIOR BREAST CANCER : A MULTICENTRE COHORT STUDY
Gastroenterology·2023
Endoscopic Submucosal Dissection in Inflammatory Bowel Disease Patients for Visible Dysplasia: a French Retrospective Multicentric Study
Endoscopy·2023
Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study
Clinics and Research in Hepatology and Gastroenterology·2023· 4 citedOpen Access
DOP89 Impact of biologics on the risk of early postoperative complications in Crohn’s disease: a French nationwide study
Journal of Crohn s and Colitis·2023· 2 citedOpen Access
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study
Digestive Diseases and Sciences·2022· 10 citedOpen Access
P604 Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study
Journal of Crohn s and Colitis·2022· 2 citedOpen Access
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus
Digestive and Liver Disease·2021· 29 citedOpen Access
Assessment of long-term results of repeated dilations and impact of a scheduled program of dilations for refractory esophageal strictures: a retrospective case–control study
Surgical Endoscopy·2021· 9 cited
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study
Clinical Gastroenterology and Hepatology·2020· 22 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Véronique Vitton(21), Morgane Mailhe(14), D. Ricaboni(14), Didier Raoult(14), Marc Barthet(11), Mélanie Serrero(11), Pierre‐Edouard Fournier(11), Aurélien Amiot(10), Laurent Peyrin‐Biroulet(9), Lucine Vuitton(8), Maria Nachury(8), Romain Altwegg(8), David Laharie(8), Jean‐Michel Gonzalez(7), Mathias Vidon(7), Ludovic Caillo(7), Cyrielle Gilletta(7), Mathurin Fuméry(7), Lucas Guillo(6), Mathieu Uzzan(6)